| Literature DB >> 34950798 |
Yu-Ki Nishimura1, Sho-Ichi Kubokawa1, Ryu-Ichiro Imai1, Yoko Nakaoka1, Koji Nishida1, Shu-Ichi Seki1, Toru Kubo2, Naohito Yamasaki2, Hiroaki Kitaoka2, Kazuya Kawai1, Naohisa Hamashige1, Yoshinori Doi1,3.
Abstract
Background: Takotsubo syndrome (TTS) in the very elderly is poorly understood. We sought to clarify the characteristics of octogenarians and nonagenarians with TTS. Methods andEntities:
Keywords: Nonagenarians; Octogenarians; Takotsubo syndrome; Uncommon emotional trigger
Year: 2021 PMID: 34950798 PMCID: PMC8651470 DOI: 10.1253/circrep.CR-21-0090
Source DB: PubMed Journal: Circ Rep ISSN: 2434-0790
Baseline Characteristics of the Entire Patient Cohort, as well as Among Octogenarians/Nonagenarians and Patients Aged ≤79 Years Separately
| Total | Age (years) | P value | ||
|---|---|---|---|---|
| ≤79 (n=80) | ≥80 (n=68) | |||
| 77±12 | 68±10 | 85±4 | ||
| Female | 120 (81) | 61 (76) | 59 (87) | 0.104 |
| Male | 28 (19) | 19 (24) | 9 (13) | 0.104 |
| Emotional | 20 (14) | 15 (19) | 5 (7) | 0.043 |
| Physical | 86 (58) | 37 (46) | 49 (72) | 0.005 |
| Infection | 29 | 10 | 19 | 0.031 |
| Respiratory | 19 | 8 | 11 | 0.263 |
| Urinary | 5 | 1 | 4 | 0.120 |
| Others | 5 | 1 | 4 | 0.212 |
| Stroke | 6 | 4 | 2 | 0.527 |
| Hemorrhage | 1 | 0 | 1 | 0.276 |
| Infarction | 3 | 2 | 1 | 0.658 |
| SAH | 2 | 2 | 0 | 0.189 |
| Fracture | 15 | 6 | 9 | 0.377 |
| Postoperative status | 9 | 5 | 4 | 0.926 |
| Respiratory diseases | 6 | 2 | 4 | 0.298 |
| Convulsion | 6 | 4 | 2 | 0.527 |
| Others | 15 | 6 | 9 | 0.249 |
| No trigger | 42 (28) | 28 (35) | 14 (21) | 0.053 |
| SBP (mmHg) | 137±31 | 134±30 | 141±32 | 0.681 |
| DBP (mmHg) | 80±19 | 81±18 | 78±20 | 0.050 |
| Heart rate (beats/min) | 88±21 | 88±19 | 87±23 | 0.881 |
| ECG | 85 (58) | 37 (46) | 48 (71) | 0.003 |
| ST elevation | 60 | 25 | 35 | 0.013 |
| T wave inversion | 20 | 10 | 10 | 0.696 |
| QT interval prolongation | 66 | 29 | 37 | 0.027 |
| Others | 5 | 2 | 3 | 0.521 |
| Chest pain/dyspnea | 58 (39) | 41 (51) | 17 (25) | 0.001 |
| Others | 5 (3) | 2 (3) | 3 (4) | 0.521 |
| Hs-cTnT (ng/mL) | 0.594±0.534 | 0.532±0.417 | 0.566±0.636 | 0.517 |
| CK-MB (ng/mL) | 33±30 | 31±26 | 36±34 | 0.598 |
| BNP (pg/mL) | 584±761 | 499±691 | 684±830 | 0.079 |
| CRP (mg/dL) | 7.22±8.37 | 5.44±6.56 | 9.15±9.64 | 0.006 |
| Apical | 125 (84) | 67 (84) | 58 (85) | 0.796 |
| Mid-apex | 86 | 45 | 41 | |
| Apex | 39 | 22 | 17 | |
| Midventricular | 14 (9) | 7 (9) | 7 (10) | 0.749 |
| Basal | 3 (1) | 2 (1) | 1 (2) | 0.658 |
| Focal | 6 (4) | 4 (5) | 2 (3) | 0.527 |
| 47±10 | 48±11 | 46±9 | ||
| IABP | 4 (3) | 4 (5) | 0 (0) | 0.062 |
| NIPPV | 1 (1) | 1 (1) | 0 (0) | 0.355 |
| Temporary pacemaker | 4 (3) | 2 (3) | 2 (3) | 0.869 |
| ACEI/ARB | 42 (28) | 18 (23) | 24 (35) | 0.085 |
| β-blocker | 23 (16) | 10 (13) | 13 (19) | 0.268 |
| CCB | 39 (26) | 23 (29) | 16 (24) | 0.472 |
| Diuretics | 39 (26) | 11 (14) | 28 (41) | <0.001 |
| 23 (16) | 15 (19) | 8 (12) | 0.242 | |
| Heart failure | 29 (20) | 9 (11) | 20 (29) | 0.006 |
| VT/VF | 6 (4) | 4 (5) | 2 (3) | 0.527 |
| AF | 6 (4) | 1 (1) | 5 (7) | 0.061 |
| Cardiac death | 2 (1) | 0 (0) | 2 (3) | 0.122 |
| Non-cardiac death | 5 (3) | 2 (3) | 3 (4) | 0.521 |
Unless indicated otherwise, data are given as the mean±SD or n (%). ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AF, atrial fibrillation; BNP, B-type natriuretic peptide; CCB, calcium channel blocker; CK-MB, creatine kinase MB; CRP, C-reactive protein; DBP, diastolic blood pressure; ECG, electrocardiogram; Hs-cTnT, high-sensitive cardiac troponin T; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; NIPPV, non-invasive positive pressure ventilation; SAH, subarachnoid hemorrhage; SBP, systolic blood pressure; VF, ventricular fibrillation; VT, ventricular tachycardia.
Baseline Characteristics for Specific Age Groups
| Age (years) | P value | ||||
|---|---|---|---|---|---|
| ≤69 (n=39) | 70–79 (n=41) | 80–89 (n=60) | 90–99 (n=8) | ||
| 60±9 | 75±3 | 84±3 | 92±2 | ||
| Female | 29 (74) | 32 (78) | 51 (85) | 8 (100) | 0.151 |
| Male | 10 (26) | 9 (22) | 9 (15) | 0 (0) | 0.151 |
| Emotional | 7 (18) | 8 (20) | 5 (8) | 0 (0) | 0.131 |
| Physical | 16 (41) | 21 (51) | 43 (72) | 6 (75) | 0.011 |
| Infection | 4 | 6 | 17 | 2 | 0.112 |
| Respiratory | 4 | 4 | 10 | 1 | 0.717 |
| Urinary | 0 | 1 | 4 | 0 | 0.178 |
| Others | 0 | 1 | 3 | 1 | 0.216 |
| Stroke | 3 | 1 | 1 | 1 | 0.326 |
| Hemorrhage | 0 | 0 | 0 | 1 | 0.113 |
| Infarction | 1 | 1 | 1 | 0 | 0.929 |
| SAH | 2 | 0 | 0 | 0 | 0.144 |
| Fracture | 1 | 5 | 8 | 1 | 0.236 |
| Postoperative status | 1 | 4 | 4 | 0 | 0.402 |
| Respiratory diseases | 1 | 1 | 4 | 0 | 0.547 |
| Convulsion | 4 | 0 | 2 | 0 | 0.076 |
| Others | 2 | 4 | 7 | 2 | 0.401 |
| No trigger | 16 (41) | 12 (29) | 12 (20) | 2 (25) | 0.162 |
| SBP (mmHg) | 140±30 | 128±30 | 142±32 | 131±30 | 0.505 |
| DBP (mmHg) | 85±17 | 77±19 | 80±21 | 67±11 | 0.266 |
| Heart rate (beats/min) | 88±22 | 88±16 | 88±23 | 80±15 | 0.340 |
| ECG | 16 (41) | 21 (51) | 41 (68) | 7 (87) | 0.010 |
| ST elevation | 12 | 13 | 29 | 6 | 0.039 |
| T wave inversion | 3 | 7 | 9 | 1 | 0.606 |
| QT interval prolongation | 11 | 18 | 33 | 4 | 0.067 |
| Others | 1 | 1 | 3 | 0 | |
| Chest pain/dyspnea | 23 (59) | 18 (44) | 16 (27) | 1 (13) | 0.003 |
| Others | 0 (0) | 2 (5) | 3 (5) | 0 (0) | |
| Hs-cTnT (ng/mL) | 0.488±0.483 | 0.563±0.405 | 0.538±0.508 | 0.739±1.203 | 0.702 |
| CK-MB (ng/mL) | 31±29 | 30±23 | 33±27 | 55±65 | 0.492 |
| BNP (pg/mL) | 322±477 | 660±815 | 618±669 | 1,089±1,490 | 0.005 |
| CRP (mg/dL) | 5.54±7.48 | 5.35±5.70 | 8.71±9.12 | 12.3±13.1 | 0.470 |
| Apical | 31 (80) | 36 (88) | 51 (85) | 7 (87) | 0.771 |
| Mid-apex | 21 | 24 | 35 | 6 | |
| Apex | 10 | 12 | 16 | 1 | |
| Midventricular | 3 (8) | 4 (10) | 7 (12) | 0 (0) | 0.559 |
| Basal | 2 (5) | 0 (0) | 1 (1) | 0 (0) | 0.337 |
| Focal | 3 (8) | 1 (2) | 1 (1) | 1 (13) | 0.326 |
| 47±11 | 48±11 | 46±9 | 50±5 | ||
| IABP | 4 (10) | 0 (0) | 0 (0) | 0 (0) | 0.012 |
| NIPPV | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 0.460 |
| Temporary pacemaker | 0 (0) | 2 (5) | 2 (3) | 0 (0) | 0.354 |
| ACEI/ARB | 4 (10) | 14 (34) | 21 (35) | 3 (38) | 0.020 |
| β-blocker | 4 (10) | 6 (15) | 10 (17) | 3 (38) | 0.350 |
| Ca-antagonist | 9 (23) | 14 (34) | 13 (22) | 3 (38) | 0.454 |
| Diuretics | 5 (13) | 6 (15) | 22 (37) | 6 (75) | <0.001 |
| 10 (26) | 5 (12) | 7 (12) | 1 (13) | 0.284 | |
| Heart failure | 3 (8) | 6 (15) | 16 (27) | 4 (50) | 0.015 |
| VT/VF | 2 (5) | 2 (5) | 2 (3) | 0 (0) | 0.820 |
| AF | 0 (0) | 1 (2) | 3 (5) | 2 (25) | 0.046 |
| Cardiac death | 0 (0) | 0 (0) | 1 (2) | 1 (12) | 0.173 |
| Non-cardiac death | 2 (5) | 0 (0) | 3 (5) | 0 (0) | 0.250 |
Data are presented as the mean±SD or n (%). Abbreviations as in Table 1.
Figure 1.Prevalence of emotional triggers of takotsubo syndrome among octogenarians/nonagenarians and patients aged ≤79 years (Left) and in the 4 age groups (Right). Emotional triggers were significantly less common among octogenarians/nonagenarians than among patients aged ≤79 years. Emotional triggers were not found in 8 nonagenarians.
Figure 2.Prevalence of physical triggers of takotsubo syndrome in octogenarians/nonagenarians and patients aged ≤79 years (Left) and in the 4 age groups (Right). Physical triggers were significantly more frequent among octogenarians/nonagenarians than among patients aged ≤79 years. Among several acute critical illnesses, the prevalence of serious infection was significant in octogenarians/nonagenarians.
Figure 3.Electrocardiogram (ECG) changes as initial clues to the diagnosis of takotsubo syndrome (TTS) in octogenarians/nonagenarians and patients aged ≤79 years (Left) and in the 4 age groups (Right). The suspected presence of TTS based on ECG changes was significantly more frequent among octogenarians/nonagenarians than among patients aged ≤79 years.
Figure 4.Subjective symptoms as initial clues to the diagnosis of takotsubo syndrome (TTS) in octogenarians/nonagenarians and patients aged ≤79 years (Left) and in the 4 age groups (Right). The suspected presence of TTS based on subjective symptoms, such as chest pain and/or dyspnea, was significantly less frequent among octogenarians/nonagenarians than among patients aged ≤79 years.